Results

Total Results: 446 records

Showing results for "drug".

21. Behavioral Health Risk Assessment for Pregnant Women Measure Technical Specifications (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/0085-tech-specs.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes

22. Declines in Hospital-Acquired Conditions (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-rates-2019-updated.pdf
    January 01, 2019 - Hospital- Acquired Conditions National efforts to reduce hospital-acquired conditions such as adverse drug … Adverse Drug Events -28% CAUTI* -5% CLABSI+ -6% Clostridioides difficile Infections -37%

23. Ncinqtobaccousehelp-References (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelp-References.pdf
    August 01, 2012 - CHIP-Program-Information/By-Topic/Early-Periodic-Screening-Diagnosis-Treatment.html National Institute on Drug … Screening for Drug Use in General Medical Settings: A Quick Reference Guide. NIH Pub No. 09-7384. … National Survey on Drug Use and Health (NSDUH). 2010 National Survey on Drug Use and Health data.

24. Number of Newborns with Neonatal Abstinence Syndrome Continued To Increase Through 2016 | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/data/infographics/neonatal-abstinence-syndrome-2016.html
    July 01, 2019 - Text Description: The number of babies born each year with withdrawal symptoms from their mother’s drug … In 2016, more than 25,000 babies were born with withdrawal symptoms from drug dependence compared with

25. Declines in Hospital-Acquired Conditions | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/data/infographics/hac-rates_2019.html
    July 01, 2020 - 11.1 MB) Text Description: National efforts to reduce hospital-acquired conditions such as adverse drug … Specific rates are: Adverse drug events: 28% decrease. CAUTI: 5% decrease. CLABSI: 6% decrease.

26. References (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

27. ADHD Behavior Therapy References (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

28. CHIPRA 212 Appendix 2 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
    January 17, 2024 - 2 APPENDIX 2 - INHALED CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d05262 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d01296 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d04276 DPI 6 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d00760 MDI 5 and older Y Y N Y ICS NDC Code Brand Name Generic Product Name Route Drug

29. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug … dysfunction 995.94 Bacteremia 790.7 Septic shock 785.52 Table 4-C: Parenteral Antibiotics Drug … Class Drug Aminoglycosides Amikacin Sulfate Gentamicin Kanamycin A Sulfate Tobramycin Sulfate … of Antibiotics for Severe Sepsis and Septic Shock U18HS020516 Page 50 Submitted August 2014 Drug … Class Drug Oxazolidinones Linezolid Penicillins Ampicillin Oxacillin Penicillin G Nafcillin

30. 1b.4_Input_File_Specifications_508 (xls file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/input-file-specifications.xlsx
    January 01, 2014 - patient was at the time the prescription was filled yes numeric Blank national_drug_code National Drug … unique identifier yes text or numeric Blank End of Table HEDIS NDC Variables HEDIS National Drug … Code (NDC) Variables Reference Name Concept Description Variable Type Note NDC_CODE National Drug … text From HEDIS Data set of asthma-related medications for data year DESCRIPTION Description of the drug … HEDIS Data set of asthma-related medications for data year DRUG_ID Unique identifier of the primary drug

31. AHRQ Stats: Hospital Admission Emergency Department Visits | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/newsletters/e-newsletter/797.html
    January 01, 2022 - 2014-2018 Later Prescribed for COVID-19 A new AHRQ data visualization shows that the respiratory drug … Users can view the total number of people who used each drug, total prescription fills, total expenditures

32. Table 4. Evidence for Prompt Antimicrobial Therapy for Treatment of Children With Severe Sepsis or Septic Shock (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-5-table-4.pdf
    January 01, 2014 - The empiric drug of choice should be changed as endemic ecologies dictate (e.g., H1N1, penicillin- … microbiological confirmation, requires consideration of patient- related characteristics, such as drug … predictors of outcome, clinicians must establish a system for rapid administration of a rationally chosen drug

33. Appendix 2: CED Compiled Public Comment Themes (xls file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-appendix2-comments.xlsx
    October 12, 2022 - Application of CED to an on-label use of a drug or biological is contrary to the requirements of the … controlled trials (RTCs) and to incorporate real-world evidence (RWE) Exclude on-label use of Food and Drug … drugs and biologicals be excluded from CED restrictions Application of CED to an on-label use of a drug … Requirements for post-FDA-approval real-world evidence development that is based on coverage to label for any drug

34. Guidelines for Translating CAHPS® Surveys | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/cahps/surveys-guidance/helpful-resources/resources/cahpsGuidelines_Translation.html
    March 01, 2016 - In the last 3 months, did you try to get information or help from your prescription drug plan’s customer … Since you joined your drug plan, how often did your drug plan’s customer service give you the information … Since you joined your drug plan, how often did your drug plan’s customer service treat you with courtesy … In the last 3 months, did you look for information from your drug plan about which prescription medicines

35. Section 1, Tables 1 to 3 (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
    April 25, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug … dysfunction 995.94 Bacteremia 790.7 Septic shock 785.52 Table 3: Parenteral Antibiotics Drug

36. AHRQ Research Helps Pharmacists in Mentoring Program to Reduce Drug Errors in Emergency Departments | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/news/newsroom/case-studies/cquips0802.html
    October 01, 2014 - Impact Case Studies AHRQ Research Helps Pharmacists in Mentoring Program to Reduce Drug … Newsletter Events AHRQ Research Helps Pharmacists in Mentoring Program to Reduce Drug … 2012 Internet Citation: AHRQ Research Helps Pharmacists in Mentoring Program to Reduce Drug

37. Table 5.A.1. Evidence Table (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
    January 01, 2014 - Pestotnik Study computerized method to improve the detection and characterization of adverse drug … Computerized surveillance of adverse drug events in hospital patients. … infections, adverse drug events (ADEs), and injurious falls. … Prevention of adverse drug events through computerized surveillance. … Medication safety program reduces adverse drug events in a community hospital.

38. Staying Active and Healthy with Blood Thinners - Transcript | Agency for Healthcare Research and Quality
    www.innovations.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/stayactive-tr.html
    September 01, 2015 - Report: Blood Thinner Medications Narrator: Recently, your doctor has prescribed a blood-thinning drug … So if you use this drug, it is important that you also be careful in your daily activities. … We hope this video helped shed some light on what a blood-thinning drug is, what it does, and how it

39. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD Jennifer Bannon RN BSN MSHI Table of Contents Objectives Cardiovascular Disease Cardiovascular Disease (2) ABCS-Aspirin when appropriate Anatomy of a Performance Measure Measure Exce…

40. 6 Tk1 T4-Be Smart About Antibiotics Final (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T4-Be_Smart_About_Antibiotics_Final.pdf
    May 01, 2014 - Be Smart About Antibiotics Taking antibiotics when you don’t need them is like leaving the lights on all the time. • The lights may burn out, leaving you in the dark when you most need them. • If you use antibiotics when you don’t need them, they may not work when you get sick. Antibiotics can help the body figh…